| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NRN2995 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/nrn2995 |
| P932 | PMC publication ID | 3335275 |
| P698 | PubMed publication ID | 21331083 |
| P5875 | ResearchGate publication ID | 49845434 |
| P50 | author | Gert Fricker | Q1515184 |
| Edward Neuwelt | Q88044074 | ||
| Costantino Iadecola | Q37345166 | ||
| Damir Janigro | Q37378626 | ||
| Luc Leybaert | Q38321237 | ||
| Christoph Fahlke | Q39064875 | ||
| Zoltán Molnár | Q41787890 | ||
| Norman Saunders | Q42706836 | ||
| P2093 | author name string | Ryan J Watts | |
| John T Povlishock | |||
| Danica Stanimirovic | |||
| Björn Bauer | |||
| Martha E O'Donnell | |||
| Frank Sharp | |||
| Lester R Drewes | |||
| P2860 | cites work | Tripartite synapses: astrocytes process and control synaptic information | Q22337308 |
| Relative CO2/NH3 selectivities of AQP1, AQP4, AQP5, AmtB, and RhAG | Q24319156 | ||
| Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging | Q24600644 | ||
| Pericytes are required for blood-brain barrier integrity during embryogenesis | Q24627396 | ||
| Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. | Q24648494 | ||
| A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells | Q24654323 | ||
| Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke | Q24657830 | ||
| Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayers. | Q47826421 | ||
| Leukoencephalopathy upon disruption of the chloride channel ClC-2. | Q48136769 | ||
| Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis | Q48141342 | ||
| Breast cancer resistance protein (Bcrp1/Abcg2) in mouse placenta and yolk sac: ontogeny and its regulation by progesterone | Q48157062 | ||
| Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat. | Q48199790 | ||
| Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type | Q48265529 | ||
| Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction | Q48299419 | ||
| Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease | Q48320745 | ||
| Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier | Q48355279 | ||
| FGF2 plays a key role in embryonic cerebrospinal fluid trophic properties over chick embryo neuroepithelial stem cells. | Q48444602 | ||
| In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation. | Q48473453 | ||
| Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. | Q48476417 | ||
| Astrocytic Ca2+ signaling evoked by sensory stimulation in vivo. | Q48540425 | ||
| The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion. | Q48564690 | ||
| The development of a blood-brain barrier mechanism in foetal sheep. | Q48567457 | ||
| Live astrocytes visualized by green fluorescent protein in transgenic mice. | Q48671250 | ||
| Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide. | Q48702178 | ||
| Cellular transfer of macromolecules across the developing choroid plexus of Monodelphis domestica. | Q48762501 | ||
| Association of a polymorphism in the ABCB1 gene with Parkinson's disease. | Q48765631 | ||
| Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. | Q48863137 | ||
| Profiling neurotransmitter receptor expression in mouse gonadotropin-releasing hormone neurons using green fluorescent protein-promoter transgenics and microarrays. | Q48924425 | ||
| Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease. | Q52024534 | ||
| Modification of protein transfer across blood/cerebrospinal fluid barrier in response to altered plasma protein composition during development. | Q53779702 | ||
| Plasma proteins in fetal sheep brain: blood-brain barrier and intracerebral distribution | Q57200033 | ||
| Molecular biology of the blood-brain barrier | Q57677372 | ||
| Development of the blood-brain barrier | Q67660260 | ||
| Cerebral vessels and glial cells in liver disease. A morphometric and electron microscopic investigation | Q70442482 | ||
| Methionine sulfoximine, a glutamine synthetase inhibitor, attenuates increased extracellular potassium activity during acute hyperammonemia | Q71934058 | ||
| Effect of glutamine synthetase inhibition on astrocyte swelling and altered astroglial protein expression during hyperammonemia in rats | Q24681887 | ||
| Cortical layer 1 and layer 2/3 astrocytes exhibit distinct calcium dynamics in vivo | Q27301015 | ||
| Astrocyte-endothelial interactions at the blood-brain barrier | Q28131675 | ||
| Occludin expression in microvessels of neoplastic and non-neoplastic human brain | Q28202259 | ||
| Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice | Q28203769 | ||
| The optogenetic catechism | Q28261583 | ||
| Biotechnology: Crossing the barrier | Q28291058 | ||
| Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier | Q28291314 | ||
| The mystery and magic of glia: a perspective on their roles in health and disease | Q28300305 | ||
| The cerebral effects of ascent to high altitudes | Q28307435 | ||
| Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature | Q28509331 | ||
| Expression of aquaporin 1 and aquaporin 4 water channels in rat choroid plexus | Q28571861 | ||
| Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier | Q28572624 | ||
| Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis | Q28594356 | ||
| Expression and localization of Na-driven Cl-HCO(3)(-) exchanger (SLC4A8) in rodent CNS | Q28594378 | ||
| Mechanisms of angiogenesis | Q29547485 | ||
| Molecular regulation of vessel maturation | Q29614540 | ||
| Tripartite synapses: glia, the unacknowledged partner | Q29615224 | ||
| The blood-brain barrier/neurovascular unit in health and disease | Q29616335 | ||
| The blood-brain barrier in health and chronic neurodegenerative disorders | Q29616411 | ||
| Astrocytes, from brain glue to communication elements: the revolution continues | Q29619493 | ||
| Microglia: a sensor for pathological events in the CNS | Q29620556 | ||
| GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak | Q30481800 | ||
| A stem cell niche for intermediate progenitor cells of the embryonic cortex | Q30488100 | ||
| A role for leukocyte-endothelial adhesion mechanisms in epilepsy | Q30488791 | ||
| Molecular imaging of proteins in tissues by mass spectrometry | Q30489516 | ||
| Canavan disease: a review of recent developments | Q30661903 | ||
| The rat blood-brain barrier transcriptome | Q33227764 | ||
| The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia | Q33325824 | ||
| Induction of blood brain barrier tight junction protein alterations by CD8 T cells | Q33363111 | ||
| Chapter 11: Imaging fluorescent mice in vivo using confocal microscopy | Q33396874 | ||
| Does pilocarpine-induced epilepsy in adult rats require status epilepticus? | Q33463300 | ||
| Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review | Q33503551 | ||
| Molecular imaging of glioblastoma multiforme using anti-insulin-like growth factor-binding protein-7 single-domain antibodies | Q33722980 | ||
| The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells | Q33741896 | ||
| Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders | Q33797048 | ||
| Matrix metalloproteinases in intracerebral hemorrhage | Q37282893 | ||
| Cerebral microvascular endothelial cell Na/H exchange: evidence for the presence of NHE1 and NHE2 isoforms and regulation by arginine vasopressin | Q37298011 | ||
| ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides. | Q37351212 | ||
| Matrix metalloproteinases and their multiple roles in neurodegenerative diseases | Q37375110 | ||
| Astrocytes and the regulation of cerebral blood flow | Q37375326 | ||
| Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain | Q37483383 | ||
| Excitatory amino acid transporters as potential drug targets. | Q37489935 | ||
| Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier | Q37494188 | ||
| Water transport between CNS compartments: contributions of aquaporins and cotransporters. | Q37599016 | ||
| T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening? | Q37625319 | ||
| Water transport between CNS compartments: functional and molecular interactions between aquaporins and ion channels | Q37660649 | ||
| Biopharmaceutical drug targeting to the brain | Q37671828 | ||
| Modeling the neurovascular niche: implications for recovery from CNS injury. | Q37677445 | ||
| Connecting vascular and nervous system development: angiogenesis and the blood-brain barrier | Q37724330 | ||
| Functions of astrocytes and their potential as therapeutic targets | Q37794378 | ||
| Regulation of ABC transporters at the blood-brain barrier: new targets for CNS therapy | Q37806476 | ||
| ABC transporters in the CNS - an inventory | Q37813717 | ||
| Effects of chronic continuous hypoxia on the expression of SLC4A8 (NDCBE) in neonatal versus adult mouse brain | Q39321427 | ||
| The development of the human blood-brain and blood-CSF barriers | Q39746567 | ||
| Label-free biomedical imaging with high sensitivity by stimulated Raman scattering microscopy | Q39903580 | ||
| Glucocorticoids regulate the human occludin gene through a single imperfect palindromic glucocorticoid response element | Q39941479 | ||
| A novel cell wall-anchored peptidoglycan hydrolase (autolysin), IspC, essential for Listeria monocytogenes virulence: genetic and proteomic analysis | Q39965413 | ||
| Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation | Q39973896 | ||
| Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells | Q40019129 | ||
| Hypothetical roles of angiogenesis, osmotic swelling, and ischemia in high-altitude cerebral edema | Q40433868 | ||
| A neurogenic basis for acute altitude illness | Q40743787 | ||
| Effects of acute hypoxia on intracellular-pH regulation in astrocytes cultured from rat hippocampus | Q40881860 | ||
| Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia | Q41677354 | ||
| Astrocyte leptin receptor (ObR) and leptin transport in adult-onset obese mice | Q36692057 | ||
| Mammalian aquaporins: diverse physiological roles and potential clinical significance | Q36697752 | ||
| Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury | Q36763899 | ||
| Inflammatory cell migration into the central nervous system: a few new twists on an old tale | Q36771887 | ||
| Cell-cell signaling in the neurovascular unit | Q36801092 | ||
| Glutamate and monoamine transporters: new visions of form and function | Q36825439 | ||
| Chemotherapy delivery issues in central nervous system malignancy: a reality check. | Q36835363 | ||
| Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development | Q36874299 | ||
| Angiogenesis in brain tumours | Q36887534 | ||
| Cerebral blood flow and cerebral edema in rats with diabetic ketoacidosis | Q36906302 | ||
| Glial regulation of the cerebral microvasculature | Q36983682 | ||
| Reperfusion activates metalloproteinases that contribute to neurovascular injury | Q36986393 | ||
| Role of ATP-binding cassette transporters in brain lipid transport and neurological disease | Q36987318 | ||
| Blood-brain barrier: structural components and function under physiologic and pathologic conditions | Q37015412 | ||
| Natalizumab: targeting alpha4-integrins in multiple sclerosis | Q37030428 | ||
| Strategies to advance translational research into brain barriers | Q37037950 | ||
| Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy | Q37080236 | ||
| Functional effectiveness of the blood-brain barrier to small water-soluble molecules in developing and adult opossum (Monodelphis domestica) | Q37080750 | ||
| The blood-CSF barrier explained: when development is not immaturity | Q37091976 | ||
| Stroke program review group: an interim report | Q37097812 | ||
| VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown | Q37100939 | ||
| PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities | Q37159206 | ||
| Barriers in the brain: a renaissance? | Q37159965 | ||
| Getting specific: monoclonal antibodies in multiple sclerosis. | Q37165875 | ||
| Review. Structure and mechanism of ATP-binding cassette transporters | Q37171513 | ||
| One of the hottest topics in epileptology: ABC proteins. Their inhibition may be the future for patients with intractable seizures | Q37204397 | ||
| Neurovascular congruence during cerebral cortical development | Q37220151 | ||
| The blood-brain barrier as a cause of obesity | Q37232868 | ||
| Targeting extracellular matrix proteolysis for hemorrhagic complications of tPA stroke therapy | Q37232887 | ||
| Cell adhesion and signaling networks in brain neurovascular units | Q37251376 | ||
| Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology | Q37259057 | ||
| Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. | Q37270464 | ||
| The origins and evolution of "controlled" drug delivery systems | Q37279442 | ||
| Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience | Q37280734 | ||
| P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model | Q41844698 | ||
| Brain metabolism dictates the polarity of astrocyte control over arterioles | Q42089441 | ||
| Plasmodium falciparum-infected erythrocytes increase intercellular adhesion molecule 1 expression on brain endothelium through NF-kappaB. | Q42408526 | ||
| Electron microscopy in human hepatic encephalopathy | Q42443638 | ||
| Signaling at the gliovascular interface. | Q42451204 | ||
| Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia | Q42475527 | ||
| Aquaporin and blood brain barrier | Q42532303 | ||
| Zebrafish model of the blood-brain barrier: morphological and permeability studies | Q42978242 | ||
| ABC transporters in cancer: more than just drug efflux pumps. | Q43193922 | ||
| Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element | Q43212996 | ||
| Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces | Q43617765 | ||
| Cerebral metabolism of ammonia and amino acids in patients with fulminant hepatic failure | Q43777301 | ||
| Pregnane X receptor (PXR) regulates P-glycoprotein at the blood-brain barrier: functional similarities between pig and human PXR. | Q43958807 | ||
| Arginine vasopressin stimulation of cerebral microvascular endothelial cell Na-K-Cl cotransporter activity is V1 receptor and [Ca] dependent | Q44173254 | ||
| Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells | Q44208778 | ||
| Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. | Q44240672 | ||
| Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition | Q44308080 | ||
| KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex | Q44815936 | ||
| Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1. | Q45025173 | ||
| Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier | Q45025187 | ||
| Calcium transients in astrocyte endfeet cause cerebrovascular constrictions | Q45051047 | ||
| The genetics of ATP-binding cassette transporters | Q45108337 | ||
| Blood-brain barrier dysfunction in parkinsonian midbrain in vivo | Q45237161 | ||
| Bumetanide reduces cerebral edema formation in rats with diabetic ketoacidosis | Q45242119 | ||
| Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. | Q45881740 | ||
| ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. | Q46191688 | ||
| MDR1A (ABCB1)-deficient CF-1 mutant mice are susceptible to cerebral malaria induced by Plasmodium berghei ANKA. | Q46273437 | ||
| The role of the blood-brain barrier Na-K-2Cl cotransporter in stroke. | Q46411365 | ||
| Moderate-to-severe ischemic conditions increase activity and phosphorylation of the cerebral microvascular endothelial cell Na+-K+-Cl- cotransporter. | Q46606304 | ||
| Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging | Q46650603 | ||
| Glutamate is critically involved in seizure-induced overexpression of P-glycoprotein in the brain | Q46659907 | ||
| Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling | Q46840766 | ||
| Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator | Q33823616 | ||
| Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease | Q33862071 | ||
| Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier | Q33900889 | ||
| P-Glycoprotein, a gatekeeper in the blood-brain barrier | Q33904245 | ||
| Drug resistance in brain diseases and the role of drug efflux transporters. | Q33988704 | ||
| Enhanced astrocytic Ca2+ signals contribute to neuronal excitotoxicity after status epilepticus | Q34048890 | ||
| Studies of the development of brain barrier systems to lipid insoluble molecules in fetal sheep | Q34053029 | ||
| Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium | Q34078957 | ||
| Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy. | Q34112939 | ||
| Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier | Q34128009 | ||
| Activation of PKC isoform beta(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain | Q34171206 | ||
| The science of stroke: mechanisms in search of treatments | Q34212337 | ||
| A dynamic switch between inhibitory and excitatory currents in a neuronal glutamate transporter | Q34245054 | ||
| Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. | Q34341174 | ||
| The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia | Q34402033 | ||
| Common mechanisms of nerve and blood vessel wiring | Q34433723 | ||
| Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging | Q34447920 | ||
| Astrocyte-mediated control of cerebral blood flow | Q34481040 | ||
| Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier | Q34502705 | ||
| Leptin signaling, adiposity, and energy balance | Q34524449 | ||
| Aquaporins in brain: distribution, physiology, and pathophysiology | Q34580267 | ||
| Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis | Q34666702 | ||
| Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation | Q34683399 | ||
| Amnionless (AMN) mutations in Imerslund-Gräsbeck syndrome may be associated with disturbed vitamin B12 transport into the CNS. | Q34734010 | ||
| Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression | Q34740072 | ||
| An alpha-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain | Q34763571 | ||
| Complex phenotype of mice lacking occludin, a component of tight junction strands. | Q34781594 | ||
| Imaging individual mRNA molecules using multiple singly labeled probes | Q34833213 | ||
| Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet | Q34892668 | ||
| Angiogenic factors in the central nervous system | Q35207666 | ||
| Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced 'chemo-fog'. | Q35645883 | ||
| Alexander disease: putative mechanisms of an astrocytic encephalopathy | Q35652990 | ||
| Neurotransmitter transporters: why dance with so many partners? | Q35690225 | ||
| Equivocal roles of tissue-type plasminogen activator in stroke-induced injury | Q35704593 | ||
| Alzheimer disease: mechanistic understanding predicts novel therapies | Q35750804 | ||
| Targeted delivery of proteins across the blood-brain barrier | Q35762072 | ||
| Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease | Q35774045 | ||
| From structure to disease: the evolving tale of aquaporin biology | Q35875999 | ||
| Regulation of brain aquaporins | Q35961491 | ||
| Neurobarrier coupling in the brain: a partner of neurovascular and neurometabolic coupling? | Q36022927 | ||
| Neurovascular mechanisms of Alzheimer's neurodegeneration | Q36088588 | ||
| Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain. | Q36136731 | ||
| The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes | Q36236149 | ||
| Multiple sclerosis -- a coordinated immune attack across the blood brain barrier | Q36268418 | ||
| From angiogenesis to neuropathology | Q36342360 | ||
| Physiology and pathophysiology of Na+/H+ exchange and Na+ -K+ -2Cl- cotransport in the heart, brain, and blood. | Q36399226 | ||
| STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier | Q36445840 | ||
| Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. | Q36457107 | ||
| Astrocyte control of synaptic transmission and neurovascular coupling. | Q36525563 | ||
| Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. | Q36559702 | ||
| Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. | Q36644315 | ||
| Glial cell aquaporin-4 overexpression in transgenic mice accelerates cytotoxic brain swelling. | Q36678507 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuroscience | Q207011 |
| P304 | page(s) | 169-182 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | Nature Reviews Neuroscience | Q2108225 |
| P1476 | title | Engaging neuroscience to advance translational research in brain barrier biology | |
| P478 | volume | 12 |
| Q30354537 | "Small Blood Vessels: Big Health Problems?": Scientific Recommendations of the National Institutes of Health Workshop. |
| Q48387586 | A 3D neurovascular microfluidic model consisting of neurons, astrocytes and cerebral endothelial cells as a blood-brain barrier |
| Q36959330 | A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells |
| Q48637776 | A method for detecting molecular transport within the cerebral ventricles of live zebrafish (Danio rerio) larvae. |
| Q35763336 | A neurovascular perspective for long-term changes after brain trauma |
| Q21195862 | A new look at cerebrospinal fluid circulation |
| Q47830673 | A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis. |
| Q35185183 | A transcriptomic atlas of mouse neocortical layers |
| Q35132580 | ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis |
| Q36744370 | African Trypanosome-Induced Blood-Brain Barrier Dysfunction under Shear Stress May Not Require ERK Activation. |
| Q47098539 | An Implantable Micro-Caged Device for Direct Local Delivery of Agents |
| Q42379321 | An Important Function of Petrosiol E in Inducing the Differentiation of Neuronal Progenitors and in Protecting Them against Oxidative Stress |
| Q33945064 | An update on the biology of sphingosine 1-phosphate receptors. |
| Q88769310 | Annexin A2 is a Robo4 ligand that modulates ARF6 activation-associated cerebral trans-endothelial permeability |
| Q38011831 | Are you in or out? Leukocyte, ion, and neurotransmitter permeability across the epileptic blood-brain barrier |
| Q38029507 | Autoimmune basal ganglia disorders |
| Q59793802 | Benchmarking in vitro tissue-engineered blood-brain barrier models |
| Q88791929 | Best practices for the use of intracerebroventricular drug delivery devices |
| Q90300767 | Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma |
| Q38156192 | Biology in prevention and treatment of brain metastases |
| Q26830903 | Blood-brain barrier and retroviral infections |
| Q33354141 | Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches |
| Q89289786 | Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection |
| Q35837961 | Blood-brain barrier modeling: challenges and perspectives |
| Q38267318 | Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics |
| Q38100970 | Blood-brain barrier structure and function and the challenges for CNS drug delivery |
| Q38222247 | Brain metastasis: new opportunities to tackle therapeutic resistance |
| Q38745594 | Building dialogues between clinical and biomedical research through cross-species collaborations. |
| Q57286577 | C Pyruvate Transport Across the Blood-Brain Barrier in Preclinical Hyperpolarised MRI |
| Q34591087 | Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury |
| Q26827093 | Cell-culture models of the blood-brain barrier |
| Q21032533 | Cerebral malaria: mysteries at the blood-brain barrier |
| Q38052687 | Cerebrovascular remodeling and epilepsy |
| Q38718158 | Cholesterol-PEG comodified poly (N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations |
| Q30968601 | Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review |
| Q39250251 | Clarifying the Ghrelin System's Ability to Regulate Feeding Behaviours Despite Enigmatic Spatial Separation of the GHSR and Its Endogenous Ligand |
| Q28535264 | Combining biochemical and imaging markers to improve diagnosis and characterization of mild traumatic brain injury in the acute setting: results from a pilot study |
| Q41886870 | Computational and Pharmacological Target of Neurovascular Unit for Drug Design and Delivery. |
| Q39387318 | Connexin Channels at the Glio-Vascular Interface: Gatekeepers of the Brain |
| Q34482628 | Connexin and pannexin signaling pathways, an architectural blueprint for CNS physiology and pathology? |
| Q38617017 | Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood-brain barrier permeability |
| Q21133671 | Consequences of repeated blood-brain barrier disruption in football players |
| Q39154908 | Cooling treatment transiently increases the permeability of brain capillary endothelial cells through translocation of claudin-5. |
| Q47119287 | Core Concept: Circumventing the blood-brain barrier |
| Q37976595 | Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers |
| Q36517378 | Dangerous leaks: blood-brain barrier woes in the aging hippocampus |
| Q36773984 | Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease |
| Q30859319 | Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances |
| Q38095360 | Developing therapeutic antibodies for neurodegenerative disease |
| Q26829668 | Development, maintenance and disruption of the blood-brain barrier |
| Q35036513 | Different permeability of potassium salts across the blood-brain barrier follows the Hofmeister series |
| Q36823757 | Diffusion of macromolecules in the brain: implications for drug delivery |
| Q34534990 | Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas |
| Q35649716 | Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder? |
| Q36986370 | Does Systemic Inflammation Play a Role in Pediatric Psychosis? |
| Q50043843 | Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the brain? |
| Q38695766 | Effect of shear stress on iPSC-derived human brain microvascular endothelial cells (dhBMECs). |
| Q33631486 | Effects of NH4CL application and removal on astrocytes and endothelial cells |
| Q36643093 | Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations. |
| Q43990563 | Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. |
| Q36072867 | Endothelial cells and astrocytes: a concerto en duo in ischemic pathophysiology |
| Q36351793 | Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke |
| Q33895903 | Far-red tracer analysis of traumatic cerebrovascular permeability |
| Q92794063 | Fast-tracking regenerative medicine for traumatic brain injury |
| Q36404218 | Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model |
| Q49795132 | Functional brain-specific microvessels from iPSC-derived human brain microvascular endothelial cells: the role of matrix composition on monolayer formation. |
| Q38160735 | Glioblastoma-initiating cells: relationship with neural stem cells and the micro-environment |
| Q38244345 | Glioma stem cells: markers, hallmarks and therapeutic targeting by metformin |
| Q28551318 | Human Brain Microvascular Endothelial Cells Derived from the BC1 iPS Cell Line Exhibit a Blood-Brain Barrier Phenotype |
| Q99589766 | Human iPSC-Derived Blood-Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development? |
| Q27027494 | Hypertension: a harbinger of stroke and dementia |
| Q49331360 | ICAM-1null C57BL/6 Mice Are Not Protected from Experimental Ischemic Stroke. |
| Q30543382 | Identification of a novel indoline derivative for in vivo fluorescent imaging of blood-brain barrier disruption in animal models |
| Q38058371 | Imaging blood-brain barrier dysfunction in animal disease models |
| Q36684162 | Immunologic privilege in the central nervous system and the blood-brain barrier |
| Q26781130 | Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein Aggregation |
| Q30576716 | Impaired neurovascular coupling to ictal epileptic activity and spreading depolarization in a patient with subarachnoid hemorrhage: possible link to blood-brain barrier dysfunction |
| Q34476565 | In vitro cerebrovascular modeling in the 21st century: current and prospective technologies |
| Q37600688 | Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging |
| Q35810745 | Insight into the cooperation of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) at the blood-brain barrier: a case study examining sorafenib efflux clearance |
| Q35708089 | Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings |
| Q37496430 | Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment |
| Q90264057 | Iron (II) Polypyridyl Complexes as Antiglioblastoma Agents to Overcome the Blood-Brain Barrier and Inhibit Cell Proliferation by Regulating p53 and 4E-BP1 Pathways |
| Q33838466 | Is peripheral immunity regulated by blood-brain barrier permeability changes? |
| Q35780018 | Ischemia-induced stimulation of cerebral microvascular endothelial cell Na-K-Cl cotransport involves p38 and JNK MAP kinases |
| Q43181089 | Isolation of primary murine brain microvascular endothelial cells |
| Q36700117 | Kruppel-like factor 2 protects against ischemic stroke by regulating endothelial blood brain barrier function |
| Q38693884 | Leveraging Optogenetic-Based Neurovascular Circuit Characterization for Repair. |
| Q59131876 | MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma |
| Q40954233 | Magnetic targeting of nanoparticles across the intact blood-brain barrier |
| Q42049544 | Making connexons in the neurovascular unit |
| Q38324539 | Metabolic syndrome and the immunological affair with the blood-brain barrier |
| Q55295930 | Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a. |
| Q93046744 | MicroRNA-126-3p Attenuates Intracerebral Hemorrhage-Induced Blood-Brain Barrier Disruption by Regulating VCAM-1 Expression |
| Q39164361 | MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis. |
| Q36588683 | Modeling the blood-brain barrier using stem cell sources |
| Q27306725 | Molecular characterisation of transport mechanisms at the developing mouse blood-CSF interface: a transcriptome approach |
| Q37523317 | Molecular contributions to neurovascular unit dysfunctions after brain injuries: lessons for target-specific drug development |
| Q38163889 | Monocarboxylate transporters in temporal lobe epilepsy: roles of lactate and ketogenic diet |
| Q36655374 | Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers |
| Q34104503 | Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents |
| Q38522125 | Nanoneurotherapeutics approach intended for direct nose to brain delivery. |
| Q36812347 | Nanoparticle transport across the blood brain barrier. |
| Q60303358 | Nanoparticle-conjugated nutraceuticals exert prospectively palliative of amyloid aggregation |
| Q35558668 | Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging |
| Q30843116 | Neural Crest Cells Contribute an Astrocyte-like Glial Population to the Spleen. |
| Q26995185 | Neural stem cell niches in health and diseases |
| Q37396577 | Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies |
| Q37976564 | Neurological diseases in relation to the blood-brain barrier |
| Q36330297 | Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease |
| Q37270697 | Neurovascular matrix metalloproteinases and the blood-brain barrier |
| Q29615839 | Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders |
| Q51745613 | Non-invasive vagus nerve stimulation reduces blood-brain barrier disruption in a rat model of ischemic stroke. |
| Q41037865 | Novel Therapeutic Effects of Leonurine On Ischemic Stroke: New Mechanisms of BBB Integrity |
| Q47249148 | One-week exposure to a free-choice high-fat high-sugar diet does not disrupt blood-brain barrier permeability in fed or overnight fasted rats. |
| Q37358086 | Optimizing superparamagnetic iron oxide nanoparticles as drug carriers using an in vitro blood-brain barrier model |
| Q38058369 | Overview and introduction: the blood-brain barrier in health and disease |
| Q48478445 | P2X7 receptors mediate innate phagocytosis by human neural precursor cells and neuroblasts. |
| Q57287906 | Pantoprazole Induces Mitochondrial Apoptosis and Attenuates NF-κB Signaling in Glioma Cells |
| Q27690845 | Pathophysiology of the neurovascular unit: disease cause or consequence? |
| Q30835318 | Pericytes from Mesenchymal Stem Cells as a model for the blood-brain barrier. |
| Q41853014 | Pharmacological modulation of blood-brain barrier increases permeability of doxorubicin into the rat brain |
| Q26861408 | Physiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug delivery |
| Q48474979 | Prenatal high-fat diet alters the cerebrovasculature and clearance of β-amyloid in adult offspring. |
| Q30746065 | Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration. |
| Q51758262 | Pretreatment with Shuanghe-Tang Extract Attenuates Postischemic Brain Injury and Edema in a Mouse Model of Stroke: An Analysis of Medicinal Herbs Listed in Dongui Bogam. |
| Q26778701 | Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer |
| Q50532471 | Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies. |
| Q48375562 | Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats |
| Q36534816 | Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury |
| Q35143491 | Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. |
| Q30359368 | Real-time monitoring of human blood-brain barrier disruption |
| Q27342762 | Reduced Contextual Discrimination following Alcohol Consumption or MDMA Administration in Mice |
| Q36460596 | Restraint Stress-Induced Morphological Changes at the Blood-Brain Barrier in Adult Rats |
| Q39205654 | Retinoic acid induces blood-brain barrier development. |
| Q28081507 | Rho kinase as a target for cerebral vascular disorders |
| Q36007494 | Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS. |
| Q89800666 | Sequential Targeting in Crosslinking Nanotheranostics for Tackling the Multibarriers of Brain Tumors |
| Q30519560 | Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage disease |
| Q35164692 | Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hits |
| Q90402270 | Sijunzi decoction may decrease apoptosis via stabilization of the extracellular matrix following cerebral ischaemia-reperfusion in rats |
| Q38269392 | Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood-Brain Barrier |
| Q46434436 | Spaceflight-Induced Intracranial Hypertension and Visual Impairment: Pathophysiology and Countermeasures |
| Q39457984 | Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms |
| Q37998107 | Strategies to minimize CNS toxicity: in vitro high-throughput assays and computational modeling |
| Q38239646 | Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy |
| Q38937398 | Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases |
| Q97540667 | TIMP1 preserves the blood-brain barrier through interacting with CD63/integrin β 1 complex and regulating downstream FAK/RhoA signaling |
| Q38190042 | TREK-king the blood-brain-barrier |
| Q36962238 | Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting |
| Q64108410 | The Blood-Brain Barrier Breakdown During Acute Phase of the Pilocarpine Model of Epilepsy Is Dynamic and Time-Dependent |
| Q30466613 | The Long and the Short of it: Gene and Environment Interactions During Early Cortical Development and Consequences for Long-Term Neurological Disease |
| Q64968356 | The Role of Antibodies and Their Receptors in Protection Against Ordered Protein Assembly in Neurodegeneration. |
| Q38745356 | The Role of Nanoparticle in Brain Permeability: An in-vitro BBB Model |
| Q36877518 | The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline |
| Q38407992 | The Use of Anthracyclines for Therapy of CNS Tumors. |
| Q35864850 | The adverse effects of air pollution on the nervous system |
| Q26753140 | The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system? |
| Q35909425 | The blood-brain barrier is disrupted in a mouse model of infantile neuronal ceroid lipofuscinosis: amelioration by resveratrol |
| Q38134725 | The blood-brain barrier: an engineering perspective. |
| Q48854235 | The influence of distributional kinetics into a peripheral compartment on the pharmacokinetics of substrate partitioning between blood and brain tissue. |
| Q55514994 | The meningeal and choroidal infiltration routes for leukocytes in stroke. |
| Q57190123 | The need for research on human brain development |
| Q38195949 | The neurovascular unit - concept review |
| Q27006033 | The pathobiology of vascular dementia |
| Q34534371 | The vasculome of the mouse brain |
| Q90420762 | Theoretical Prediction of the Complex P-Glycoprotein Substrate Efflux Based on the Novel Hierarchical Support Vector Regression Scheme |
| Q57071940 | Theranostic applications of nanoparticles in neurodegenerative disorders |
| Q39479822 | Theranostic implications of nanotechnology in multiple sclerosis: a future perspective. |
| Q36731242 | Translational Stroke Research on Blood-Brain Barrier Damage: Challenges, Perspectives, and Goals. |
| Q26830912 | Traumatic brain injury, neuroinflammation, and post-traumatic headaches |
| Q48348672 | Treatment of penetrating brain injury in a rat model using collagen scaffolds incorporating soluble Nogo receptor |
| Q28539271 | Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system |
| Q28072473 | Utilizing pharmacotherapy and mesenchymal stem cell therapy to reduce inflammation following traumatic brain injury |
| Q48016461 | Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier |
| Q37480076 | Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine. |
| Q33639014 | Vascular neural network phenotypic transformation after traumatic injury: potential role in long-term sequelae |
| Q50534038 | Vascular tight junction disruption and angiogenesis in spontaneously hypertensive rat with neuroinflammatory white matter injury. |
| Q26781557 | Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions |
| Q55439840 | Vitexin reduces epilepsy after hypoxic ischemia in the neonatal brain via inhibition of NKCC1. |
| Q90082196 | XingNaoJing injections protect against cerebral ischemia/reperfusion injury and alleviate blood-brain barrier disruption in rats, through an underlying mechanism of NLRP3 inflammasomes suppression |
| Q26748774 | miRNAs Participate in MS Pathological Processes and Its Therapeutic Response |
Search more.